Abstract
Purpose of Review
Improved contraceptive use has been cited as the main contributor to the dramatic decrease in adolescent pregnancy and birth in the USA. This review will explore empirical literature that underlies the recent trends in contraceptive use for adolescents.
Recent Findings
Three major categories of findings were identified in our review. First, formal contraceptive practice recommendations from the Centers for Disease Control and Prevention remove some barriers to contraceptive care that may be particularly relevant for adolescents. The most important of these (1) indicates that the use of any contraceptive should not be limited to age or parity alone and (2) supports immediate initiation when appropriate. Implementation of these recommendations into clinical care is variable, and barriers to adopting evidence-based practices are complex. Second, a substantial body of literature has accumulated around the use of long-acting reversible contraception (LARC) in adolescents. Adolescents have high acceptance of LARC when it is offered, high continuation, and high satisfaction. Interventions that improved adolescent contraception with increased LARC use have resulted in decreased teen pregnancy, birth, and abortion. Third, emerging research focuses on innovations regarding approach and location of contraceptive service delivery for adolescents, including non-primary care clinical settings, school-based settings, and over-the-counter.
Summary
Improved contraception for adolescents has been multifactorial and impactful. Dissemination and implementation of these recent findings as well as ongoing study of innovations that meet the unique needs of adolescents will continue this trend.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Martin JA, Hamilton BE, Osterman MJ, Births in the United States. NCHS. Data Brief. 2015;2016(258):1–8.
Counting It Up: Key Data. 2013, The National Campaign to Prevent Teen and Unplanned Pregnancy.
Santelli JS, et al. Explaining recent declines in adolescent pregnancy in the United States: the contribution of abstinence and improved contraceptive use. Am J Public Health. 2007;97(1):150–6.
• Lindberg L, Santelli J, Desai S. Understanding the decline in adolescent fertility in the United States, 2007-2012. J Adolesc Health. 2016;59(5):577–83. This study evaluates the factors that underlie the more recent reduction in teen birth.
Richards MJ, Buyers E. Update on adolescent contraception. Adv Pediatr Infect Dis. 2016;63(1):429–51.
Hartman LB, Monasterio E, Hwang LY. Adolescent contraception: review and guidance for pediatric clinicians. Curr Probl Pediatr Adolesc Health Care. 2012;42(9):221–63.
Martinez GM, Abma JC. Sexual activity, contraceptive use, and childbearing of teens aged 15-19 in the United States. NCHS Data Brief. 2015. No. 209.
Branum AM, Jones J. Trends in long-acting reversible contraception use among U.S. women aged 15-44. NCHS Data Brief. 2015;(188): p. 1–8.
U. S. Medical Eligibility Criteria for Contraceptive Use. MMWR Recomm Rep. 2010;59(RR-4):1–86.
•• Curtis KM, et al. U.S. Medical Eligibility Criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016;65(3):1–103. This is an essential document for the delivery of contraception to anyone of any age. Available in multiple modalities including an app and an e-book.
U.S. Selected Practice Recommendations for Contraceptive Use, 2013. Adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. MMWR Recomm Rep. 2013;62(RR-05):1–60.
•• Curtis KM, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep. 2016;65(4):1–66. This is an essential document for the delivery of contraception to anyone of any age. Available in multiple modalities including an app and an e-book.
Tepper NK, Marchbanks PA, Curtis KM. Use of a checklist to rule out pregnancy: a systematic review. Contraception. 2013;87(5):661–5.
Min J, et al. Performance of a checklist to exclude pregnancy at the time of contraceptive initiation among women with a negative urine pregnancy test. Contraception. 2015;91(1):80–4.
Whiteman MK, et al. Using a checklist to assess pregnancy in teenagers and young women. Obstet Gynecol. 2014;123(4):777–84.
Usinger KM, et al. Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol. 2016;29(6):659–67.
Birgisson NE, et al. Positive testing for Neisseria gonorrhoeae and chlamydia trachomatis and the risk of pelvic inflammatory disease in IUD users. J Women’s Health (Larchmt). 2015;24(5):354–9.
• Hoopes AJ, et al. 2016 updates to US Medical eligibility criteria for contraceptive use and selected practice recommendations for contraceptive use: highlights for adolescent patients. J Pediatr Adolesc Gynecol. 2017. This is a summary of key components of the MEC and SPR with an adolescent focus.
Centers for Disease Control. June 1, 2017; Available from: https://www.cdc.gov/reproductivehealth/contraception/unintendedpregnancy/training.htm.
ACOG Committee Opinion No. 577. Understanding and using the U.S. Selected Practice Recommendations for Contraceptive Use. Obstet Gynecol. 2013;122(5):1132–3.
Klein DA, Arnold JJ, Reese ES. Provision of contraception: key recommendations from the CDC. Am Fam Physician. 2015;91(9):625–33.
Romero LM, et al. Improving the implementation of evidence-based clinical practices in adolescent reproductive health care services. J Adolesc Health. 2015;57(5):488–95.
• Romero LM, et al. Efforts to increase implementation of evidence-based clinical practices to improve adolescent-friendly reproductive health services. J Adolesc Health. 2017;60(3S):S30–7. This is an important study that explores the challenges of putting evidence-based recommendations into practice. It is one of the few that look to implementation science in the field of inquiry.
Hallum-Montes R, et al. Barriers and facilitators to health center implementation of evidence-based clinical practices in adolescent reproductive health services. J Adolesc Health. 2016;58(3):276–83.
Pritt NM, Norris AH, Berlan ED. Barriers and facilitators to adolescents’ use of long-acting reversible contraceptives. J Pediatr Adolesc Gynecol. 2017;30(1):18–22.
Biggs MA, et al. Same-day LARC insertion attitudes and practices. Contraception. 2013;88(5):629–35.
Berlan ED, Pritt NM, Norris AH. Pediatricians’ attitudes and beliefs about long-acting reversible contraceptives influence counseling. J Pediatr Adolesc Gynecol. 2017;30(1):47–52.
Rubin SE, et al. Louisiana and Mississippi family physicians’ contraception counseling for adolescents with a focus on intrauterine contraception. J Pediatr Adolesc Gynecol. 2016;29(5):458–63.
Rubin SE, Campos G, Markens S. Primary care physicians’ concerns may affect adolescents’ access to intrauterine contraception. J Prim Care Community Health. 2013;4(3):216–9.
ACOG Committee opinion no. 539. Adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2012;120(4):983–8.
Committee on Adolescence. Contraception for adolescents. Pediatrics. 2014;134(4):e1244–56.
•• Ott MA, Sucato GS, Committee on Adolescence. Contraception for adolescents. Pediatrics. 2014;134(4):e1257–81. This is the technical document published by the AAP that provides guidance for pediatricians in contraception for adolescents. It is important and pragmatic.
• McNicholas C, et al. The contraceptive CHOICE project round up: what we did and what we learned. Clin Obstet Gynecol. 2014;57(4):635–43. A summary of key findings of the CHOICE project, adolescents and adults.
Diedrich JT, et al. Three-year continuation of reversible contraception. Am J Obstet Gynecol. 2015;213(5):662 e1–8.
• Winner B, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366(21):1998–2007. This is a landmark study that demonstrates that LARC methods work much better at preventing unintended pregnancy in a cohort of women.
•• Secura GM, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med. 2014;371(14):1316–23. A CHOICE project study that demonstrates dramatic decreases in teen pregnancy, birth, and abortion during the study period.
•• Ricketts S, Klingler G, Schwalberg R. Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women. Perspect Sex Reprod Health. 2014;46(3):125–32. This study demonstrates the impact of a state-wide approach to improving contraceptive delivery for young women.
Diedrich JT, Klein DA, Peipert JF, Long-acting reversible contraception in adolescents: a systematic review and meta-analysis. Am J Obstet Gynecol. 2016.
•• Tocce KM, Sheeder JL, Teal SB. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference? Am J Obstet Gynecol. 2012;206(6):481.e1–7. This is one of the first studies that shows the potential impact of offering teen mothers highly effective contraception after birth.
Wilson S, et al. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation. Contraception. 2014;90(3):259–64.
Cohen R, et al. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices. Contraception. 2016;93(2):178–83.
Damle LF, et al. Early initiation of postpartum contraception: does it decrease rapid repeat pregnancy in adolescents? J Pediatr Adolesc Gynecol. 2015;28(1):57–62.
Han L, et al. Preventing repeat pregnancy in adolescents: is immediate postpartum insertion of the contraceptive implant cost effective? Am J Obstet Gynecol. 2014;211(1):24.e1–7.
Teal SB, et al. Insertion characteristics of intrauterine devices in adolescents and young women: success, ancillary measures, and complications. Am J Obstet Gynecol. 2015;213(4):515.e1–5.
Madden T, et al. Association of age and parity with intrauterine device expulsion. Obstet Gynecol. 2014;124(4):718–26.
Garbers S, et al. Continuation of copper-containing intrauterine devices at 6 months. Contraception. 2013;87(1):101–6.
Ravi A, et al. Intrauterine devices at six months: does patient age matter? Results from an urban family medicine federally qualified health center (FQHC) network. J Am Board Fam Med. 2014;27(6):822–30.
Aoun J, et al. Effects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol. 2014;123(3):585–92.
Behringer T, et al. Duration of use of a levonorgestrel IUS amongst nulliparous and adolescent women. Contraception. 2011;84(5):e5–e10.
Maslyanskaya S, et al. Predictors of early discontinuation of effective contraception by teens at high risk of pregnancy. J Pediatr Adolesc Gynecol. 2016;29(3):269–75.
Grunloh DS, et al. Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use. Obstet Gynecol. 2013;122(6):1214–21.
Hoggart L, Newton VL, Dickson J. “I think it depends on the body, with mine it didn’t work”: explaining young women’s contraceptive implant removal. Contraception. 2013;88(5):636–40.
Lunde B, et al. “Just wear dark underpants mainly”: learning from adolescents’ and young adults’ experiences with early discontinuation of the contraceptive implant. J Pediatr Adolesc Gynecol. 2017.
Deokar AM, Jackson W, Omar HA. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant. Int J Adolesc Med Health. 2011;23(1):75–7.
Hoggart L, Newton VL. Young women’s experiences of side-effects from contraceptive implants: a challenge to bodily control. Reprod Health Matters. 2013;21(41):196–204.
Gomez AM, et al. Do knowledge and attitudes regarding intrauterine devices predict interest in their use? Womens Health Issues. 2015;25(4):359–65.
Kumar N, Brown JD. Access barriers to long-acting reversible contraceptives for adolescents. J Adolesc Health. 2016;59(3):248–53.
Teal SB, Romer SE. Awareness of long-acting reversible contraception among teens and young adults. J Adolesc Health. 2013;52(4 Suppl):S35–9.
Barrett M, et al. Awareness and knowledge of the intrauterine device in adolescents. J Pediatr Adolesc Gynecol. 2012;25(1):39–42.
Potter J, Rubin SE, Sherman P. Fear of intrauterine contraception among adolescents in New York City. Contraception. 2014;89(5):446–50.
Sundstrom B, Baker-Whitcomb A, DeMaria AL. A qualitative analysis of long-acting reversible contraception. Matern Child Health J. 2015;19(7):1507–14.
• Kavanaugh ML, et al. Long-acting reversible contraception for adolescents and young adults: patient and provider perspectives. J Pediatr Adolesc Gynecol. 2013;26(2):86–95. This study is important for every clinician to read and helps illustrate that what is important to us as providers may not be so important to patients.
Dehlendorf C, et al. A qualitative analysis of approaches to contraceptive counseling. Perspect Sex Reprod Health. 2014;46(4):233–40.
Gavin L, et al. Providing quality family planning services: recommendations of CDC and the U.S. Office of Population Affairs. MMWR Recomm Rep. 2014;63(RR-04):1–54.
Copen CE, Dittus PJ, and Leichliter JS. Confidentiality concerns and sexual and reproductive health care among adolescents and young adults aged 15-25. NCHS data brief, 2016. no 266.
State Laws and Policies: An Overview of Minors’ Consent Law. Guttmacher Institute; 2017.
ACOG Committee Opinion no. .599: Committee on Adoscent Health Care: adolescent confidentiality and electronic health records. Obstet Gynecol. 2014;123(5):1148–50.
Ford C, English A, Sigman G. Confidential health care for adolescents: position paper for the society for adolescent medicine. J Adolesc Health. 2004;35(2):160–7.
Minguez M, et al. Reproductive health impact of a school health center. J Adolesc Health. 2015;56(3):338–44.
Sangraula M, et al. Integrating long-acting reversible contraception services into New York City school-based health centers: quality improvement to ensure provision of youth-friendly services. J Pediatr Adolesc Gynecol. 2016.
Daley AM. Contraceptive services in SBHCs: a community experience in creating change. Policy Polit Nurs Pract. 2011;12(4):208–14.
Ethier KA, et al. School-based health center access, reproductive health care, and contraceptive use among sexually experienced high school students. J Adolesc Health. 2011;48(6):562–5.
Guss CE, et al. Using the hospital as a venue for reproductive health interventions: a survey of hospitalized adolescents. Hosp Pediatr. 2015;5(2):67–73.
Schwarz EB, et al. Computer-assisted provision of hormonal contraception in acute care settings. Contraception. 2013;87(2):242–50.
Chernick LS, et al. Barriers to and enablers of contraceptive use among adolescent females and their interest in an emergency department based intervention. Contraception. 2015;91(3):217–25.
Chernick LS, et al. Enhancing referral of sexually active adolescent females from the emergency department to family planning. J Women’s Health (Larchmt). 2015;24(4):324–8.
Koyama A, Dorfman DH, Forcier MM. Long-acting reversible contraception in the pediatric emergency department: clinical implications and common challenges. Pediatr Emerg Care. 2015;31(4):286–92. quiz 293-5
Gonsalves L, Hindin MJ. Pharmacy provision of sexual and reproductive health commodities to young people: a systematic literature review and synthesis of the evidence. Contraception. 2016.
Manski R, Kottke M. A survey of teenagers’ attitudes toward moving oral contraceptives over the counter. Perspect Sex Reprod Health. 2015;47(3):123–9.
Upadhya KK, et al. Over-the-counter access to oral contraceptives for adolescents. J Adolesc Health. 2017;60(6):634–40.
Hall KS, Westhoff CL, Castaño PM. The impact of an educational text message intervention on young urban women’s knowledge of oral contraception. Contraception. 2013;87(4):449–54.
Hall KS, Castaño PM, Westhoff CL. The influence of oral contraceptive knowledge on oral contraceptive continuation among young women. J Women’s Health (Larchmt). 2014;23(7):596–601.
Crosby R, Salazar LF. Reduction of condom use errors from a brief, clinic-based intervention: a secondary analysis of data from a randomised, controlled trial of young black males. Sex Transm Infect. 2015;91(2):111–5.
Williams RL, Fortenberry JD. Update on adolescent condom use. Curr Opin Obstet Gynecol. 2011;23(5):350–4.
Brown JL, et al. Multiple method contraception use among African American adolescents in four US cities. Infect Dis Obstet Gynecol. 2011;2011:765917.
Higgins JA, et al. Dual method use at last sexual encounter: a nationally representative, episode-level analysis of US men and women. Contraception. 2014;90(4):399–406.
Hood JE, et al. Dual contraceptive use among adolescents and young adults: correlates and implications for condom use and sexually transmitted infection outcomes. J Fam Plann Reprod Health Care. 2014;40(3):200–7.
Kottke M, et al. Use of dual methods for protection from unintended pregnancy and sexually transmitted diseases in adolescent African American women. J Pediatr Adolesc Gynecol. 2015;28(6):543–8.
Williams RL, Fortenberry JD. Dual use of long-acting reversible contraceptives and condoms among adolescents. J Adolesc Health. 2013;52(4 Suppl):S29–34.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Tiffany Hailstorks declares no conflict of interest.
Melissa Kottke reports personal fees from Merck and Evofem, Inc.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Family Planning
Rights and permissions
About this article
Cite this article
Kottke, M., Hailstorks, T. Improvements in Contraception for Adolescents. Curr Obstet Gynecol Rep 6, 189–197 (2017). https://doi.org/10.1007/s13669-017-0214-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13669-017-0214-2